AMETEK director receives 950-share restricted stock grant

AMATO THOMAS A reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

AMATO THOMAS A reported acquisition or exercise transactions in this Form 4 filing.

AMETEK director Thomas A. Amato received a grant of 950 shares of restricted common stock, valued at $212.77 per share, under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. This is a compensation-related award rather than an open-market purchase.

After the grant, he directly holds 5,010 common shares. The filing also shows an additional 6,500 common shares held indirectly by a trust, giving him both direct and indirect exposure to AMETEK stock.

Insights

Equity compensation analyst

Routine director equity grant increases alignment through restricted stock.

The filing shows director Thomas A. Amato received 950 shares of AMETEK common stock as restricted stock under the 2020 Omnibus Incentive Compensation Plan. Grants like this are standard board compensation and do not represent an open-market share purchase.

Following the grant, Amato holds 5,010 shares directly, plus 6,500 shares held indirectly by a trust. This mix of direct and indirect ownership provides ongoing equity exposure, but the scale and compensation nature suggest a routine governance practice rather than a thesis-changing event.

Insider Trade Summary

Grant/Award: 950 shares

Grant/Award 2 txns

Insider AMATO THOMAS A

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	950	$212.77	$202K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 5,010 shares (Direct); Common Stock — 6,500 shares (Indirect, By Trust)

Footnotes (1)

1. F1. Constitutes restricted stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did AMETEK (AME) director Thomas A. Amato report in this Form 4?

Thomas A. Amato reported receiving 950 shares of AMETEK common stock as restricted stock under the 2020 Omnibus Incentive Compensation Plan. This is a compensation-related equity award, not an open-market trade, and increases his direct ownership position in the company.

Is the AMETEK (AME) Form 4 transaction a stock purchase or an equity award?

The Form 4 reflects an equity award, not a market purchase. Amato received 950 restricted shares granted under AMETEK’s 2020 Omnibus Incentive Compensation Plan, which is a typical form of director compensation aimed at aligning board members with shareholder interests over time.

How many AMETEK (AME) shares does Thomas A. Amato hold after this Form 4 grant?

After the grant, Amato holds 5,010 AMETEK common shares directly. The filing also shows 6,500 additional common shares held indirectly by a trust, giving him both direct and indirect exposure to the company’s equity according to the reported ownership details.

What is the value per share of the AMETEK (AME) restricted stock granted to Thomas A. Amato?

The restricted stock grant is reported at $212.77 per share for the 950 common shares. This figure represents the per-share value used in the Form 4 and helps quantify the size of the equity-based compensation award to the director.

What plan governs the restricted stock grant reported in the AMETEK (AME) Form 4?

The 950-share restricted stock grant was issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. This plan authorizes equity-based awards, such as restricted stock, to directors and other participants as part of the company’s long-term incentive compensation structure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/18/2026 - 06:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

AMATO THOMAS A

(Last) (First) (Middle)

AMETEK, INC.

1100 CASSATT ROAD

(Street)

BERWYN PENNSYLVANIA 19312

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AMETEK INC/ [ AME ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/18/2026		A(1)		950	A	$212.77	5,010	D
Common Stock								6,500	I	By Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Constitutes restricted stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan.

Remarks:

	/s/ Lynn Carino, attorney-in-fact for Mr. Amato	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)